SCHEMBL7956246

SCHEMBL7956246

N#Cc1ccc(N2CCN(c3ccncc3)CC2)c(CNS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
CYP19A1 P11511 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
AVPR1B P47901 4/20 0.41
NAMPT P43490 3/20 0.40
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
MAPT P10636 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
SLC22A12 Q96S37 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956239 0.88 CYP19A1 (0.46) SMN1; SMN2LMNACYP19A1MEN1KMT2A
SCHEMBL7956464 0.85 SMN1; SMN2 (0.47) SMN1; SMN2LMNACYP19A1MEN1KMT2A
SCHEMBL7947312 0.82 SLC22A12 (0.50) SMN1; SMN2LMNAMEN1KMT2AAVPR1B
SCHEMBL7958994 0.82 GFER (0.50) SMN1; SMN2LMNAKMT2AMAPT
SCHEMBL7956448 0.78 HTT (0.46) NAMPT
SCHEMBL7956244 0.78 CYP19A1 (0.65) SMN1; SMN2LMNACYP19A1MEN1KMT2A
SCHEMBL7956458 0.76 POLB (0.51) SMN1; SMN2LMNACYP19A1MEN1KMT2A
SCHEMBL7958300 0.76 KMT2A (0.53) SMN1; SMN2LMNAMEN1KMT2ACYP1A2
SCHEMBL7947310 0.74 MCOLN3 (0.50) NAMPTSLC22A12
SCHEMBL7958986 0.73 HTR7 (0.51) SMN1; SMN2MEN1KMT2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed